Skip to search formSkip to main contentSkip to account menu

R 101933

Known as: R-101933, R101933 
National Institutes of Health

Related topics

Related topics

1 relation

Broader (1)

laniquidar

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2009
2009
Increase in morphine antinociceptive activity by a P-glycoprotein inhibitor in cisplatin-induced neuropathy
Highly Cited
2002
Highly Cited
2002
Disposition of docetaxel in the presence of P-glycoprotein inhibition by intravenous administration of R101933.
2000
2000
99mTc-MIBI scintigraphies for the pharmacodynamic evaluation of R101933: A new inhibitor of the MDR-1 P-glycoprotein (PgP)
2000
2000
Pharmacologic modulation of taxanes
textabstractIn the 90's the taxanes paclitaxel and docetaxel, both belonging to the so-called naturally occurring drugs, because… 
1999
1999
A clinical pharmacodynamic (Pd) and pharmacokinetic (Pk) phase I study of I.V. R101933, an inhibitor of MDR1 P-glycoprotein (PgP) given alone and in combination with Taxol in patients with solid…
1999
1999
Oral R101933, an inhibitor of MDR1 P-glyco-protein does not significantly after the pharmacokinetics and pharmacodynamics of Paclitaxel
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy (opens in a new tab), Terms of Service (opens in a new tab), and Dataset License (opens in a new tab)